Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2023 | 1641 | 0.560 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1434 | 0.410 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2898 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 4521 | 0.280 |
Why?
|
| Azacitidine | 1 | 2024 | 335 | 0.200 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2023 | 419 | 0.200 |
Why?
|
| Culture Media, Conditioned | 1 | 2023 | 520 | 0.200 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 496 | 0.170 |
Why?
|
| Drug Synergism | 2 | 2024 | 1755 | 0.170 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 193 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 997 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 428 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2020 | 328 | 0.140 |
Why?
|
| Sulfonamides | 2 | 2024 | 1978 | 0.140 |
Why?
|
| Receptors, Notch | 1 | 2021 | 751 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2020 | 657 | 0.140 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 604 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.120 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 384 | 0.120 |
Why?
|
| Interleukins | 2 | 2017 | 794 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1352 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 1155 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2015 | 238 | 0.100 |
Why?
|
| Leukemia | 1 | 2020 | 1521 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 17082 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1405 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11872 | 0.090 |
Why?
|
| Killer Cells, Natural | 2 | 2017 | 2210 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3943 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2017 | 1374 | 0.080 |
Why?
|
| Apoptosis | 6 | 2021 | 9507 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2839 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3735 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6778 | 0.070 |
Why?
|
| Receptors, Interleukin-21 | 2 | 2017 | 32 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 5194 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5334 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3635 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1594 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13639 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18322 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2023 | 23611 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4784 | 0.050 |
Why?
|
| Daptomycin | 1 | 2021 | 71 | 0.050 |
Why?
|
| Ikaros Transcription Factor | 1 | 2022 | 230 | 0.040 |
Why?
|
| Mice | 4 | 2021 | 81863 | 0.040 |
Why?
|
| Clone Cells | 1 | 2021 | 1670 | 0.040 |
Why?
|
| Humans | 11 | 2024 | 766351 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2018 | 697 | 0.030 |
Why?
|
| Gene Expression | 2 | 2022 | 7583 | 0.030 |
Why?
|
| Animals | 5 | 2021 | 168887 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2626 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2017 | 199 | 0.030 |
Why?
|
| Half-Life | 1 | 2017 | 648 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 1150 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 281 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6105 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 696 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2018 | 1260 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2022 | 12147 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 872 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2979 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2017 | 3159 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6217 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3676 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12825 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15563 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14466 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10438 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3407 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8619 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2825 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5924 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9539 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7475 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4410 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9521 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29921 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2015 | 4749 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22337 | 0.010 |
Why?
|
| Female | 2 | 2021 | 396307 | 0.010 |
Why?
|
| Male | 1 | 2021 | 363931 | 0.000 |
Why?
|
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_